Skip to content

Educational & research information only — not medical advice. Consult a qualified healthcare professional about your health.

NNextGen Pro Help
← Product Library

Tesamorelin

FDA-approved (specific indication)

Tesamorelin 10MG

A growth-hormone-releasing hormone (GHRH) analog with an FDA-approved medical indication.

What is Tesamorelin?

Tesamorelin is a synthetic version of a natural signaling hormone (GHRH) that prompts the pituitary gland to release growth hormone. It is notable because, unlike most research peptides, it has an FDA-approved prescription medicine form for a specific medical condition.

Tesamorelin is a stabilized analog of human growth-hormone-releasing hormone (GHRH 1-44). It binds GHRH receptors on the anterior pituitary, stimulating endogenous, pulsatile growth hormone secretion, which in turn raises IGF-1. Its FDA-approved form (marketed as Egrifta) is indicated to reduce excess abdominal fat in HIV-associated lipodystrophy.

Why researchers study it

Evidence varies by area. We label each honestly and avoid guaranteed health claims.

HIV-associated lipodystrophy (approved indication)

High evidence

Basis of FDA approval for the prescription product.

Growth hormone / IGF-1 axis

Moderate evidence

Well-characterized GHRH mechanism.

Other investigational uses

Preliminary evidence

Explored in research; not approved indications.

How it works

A simplified view — understandable with zero medical background.

1

GHRH receptor

Tesamorelin binds GHRH receptors on the pituitary gland.

2

GH release

This stimulates the body's own pulsatile growth hormone release.

3

IGF-1

Growth hormone raises IGF-1, mediating downstream effects.

Storage, handling & safety

Storage

The approved prescription product has specific refrigeration and reconstitution instructions in its labeling. Research-supplied lyophilized peptide is generally kept cold and protected from light.

Handling

Follow the manufacturer or product documentation. Keep vials labeled and use clean technique.

Safety

If you are considering tesamorelin for a health reason, this is a prescription decision for a licensed clinician. Do not use approved-medicine dosing information to guide research material or vice-versa.

Supplies & preparation (education)

General educational descriptions only. This does not tell you which syringe to use for a specific compound, and does not turn supply sizes into dosing guidance.

  • Alcohol Prep Pads

    Individually wrapped alcohol wipes used to clean surfaces in a general research context.

  • 3 mL Sterile Syringes

    3 mL syringes are commonly used for transferring measured liquid in laboratory settings. This is a general description, not a recommendation about administering any compound.

  • FDA-Cleared Sharps Disposal Container

    A puncture-resistant container cleared for the disposal of sharps.

  • Labels

    Labels for keeping vials and containers clearly identified with contents and date.

Preparation guide

Reconstitution information published by NextGen for this product, with the concentration worked out. This is preparation education — not a personal dose or schedule.

Standard

Provided by NextGen

Vial strength

10 mg

Add bacteriostatic water

1 mL

Resulting concentration

10 mg/mL

Adding 1 mL of bacteriostatic water to a 10 mg lyophilized powder vial gives a concentration of 10 mg/mL — that is, every 1 mL of the mixed liquid contains 10 mg. This is the arithmetic of the values NextGen published.

Preparation notes

Mix 1 ML of Bac water, then take 4 units for 5 days and increase 2 units every 5 till you reach 10. take at night.

After mixing: DO NOT KEEP IN FRIDGE. Store in dark.

Preparation information published by NextGen. This describes how to reconstitute the vial — it is not a personal dose, injection amount, or schedule. Always follow the directions given to you by a qualified professional and verify against the markings on your own supplies.

Watch & learn

Relevant third-party educational videos. Independent sources — not medical advice or an endorsement.

What people commonly report

These would be anecdotal, self-reported experiences — not proven medical outcomes, and kept entirely separate from clinical evidence. NextGen doesn't invent reports or percentages, so this section stays empty until real, reviewed reports are collected.

Research reviewed: continuously updated by an administrator.

Questions about Tesamorelin?

NextGen AI can answer research-education questions using approved sources.